Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CMS “Actively” Pursuing Discussions On Oncology Demo Extension

Executive Summary

The Centers for Medicare & Medicaid Services will base a decision on whether to extend the Medicare "quality of care" oncology demonstration project into 2006 on input from providers, patient groups and other stakeholders

You may also be interested in...

Epogen Part B Payments To Be Based On ASP In All Dialysis Centers – CMS

Medicare will reimburse Amgen's Epogen (epoetin alfa) at the average sales price plus 6% in freestanding and hospital-based dialysis facilities in 2006 under the proposed FDL-1Physician Fee Schedule for 2006, announced Aug. 1

Cancer “Quality Of Care” Demo Should Be Extended, House Cmte. Tells CMS

The House Energy & Commerce Committee recommended that the Centers for Medicare & Medicaid Services extend the oncology "quality of care" demonstration project for another year

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts